| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/22/2009 | CN101485890A Fluorocarbon nano medicine-carrying system and preparation method thereof |
| 07/22/2009 | CN101485889A Defecography agent |
| 07/21/2009 | US7565191 Tissue site markers for in vivo imaging |
| 07/21/2009 | US7563902 Chemiluminescent compounds and their use |
| 07/21/2009 | US7563819 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/16/2009 | WO2009089500A1 Telemetry through remote detection of nmr-active particles |
| 07/16/2009 | WO2009089110A2 Methods for repair and regeneration of bone marrow |
| 07/16/2009 | WO2009089022A1 N-alkoxyamide conjugates as imaging agents |
| 07/16/2009 | WO2009088876A2 Transgenic non-human animals expressing human blood clotting factors |
| 07/16/2009 | WO2009088801A1 Bifunctional and trifunctional nitrone spin trapping compounds and uses thereof |
| 07/16/2009 | WO2009087253A1 Tubular nanostructured materials having anisotropic magnetic properties, method for obtaining same and use thereof |
| 07/16/2009 | WO2009054853A9 Loadable polymeric particles for cosmetic and reconstructive tissue augmentation applications and methods of preparing and using the same |
| 07/16/2009 | WO2009042168A3 Magnetic resonance contrast using fictitious field relaxation |
| 07/16/2009 | WO2008153744A3 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/16/2009 | WO2008139480A3 Assessment of blood-brain barrier disruption |
| 07/16/2009 | US20090182119 Catalytically active peptides |
| 07/16/2009 | US20090181414 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/16/2009 | US20090180967 Ultrsonically active microparticles and method of use |
| 07/16/2009 | US20090180965 Methods for repair and regeneration of bone marrow |
| 07/16/2009 | US20090180964 Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans |
| 07/16/2009 | US20090180963 Formulations for use in medical and diagnostic procedures |
| 07/16/2009 | US20090180962 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 07/16/2009 | US20090180961 Screening a candidate compound for antiinflammatory activity by administering the candidate in vivo to cells of an animal that express a Reso E receptor; reduced expression of interleukin-12 and reduced migration of dendritic cells into T-cell areas of the spleen indicates a good candidate |
| 07/16/2009 | US20090180960 Diagnosis and treatment of diseases involving platelet activation |
| 07/16/2009 | US20090180959 VDCC Gamma-8 Ion Channel |
| 07/16/2009 | US20090180958 Diagnostic and therapeutic agents |
| 07/16/2009 | US20090180957 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 07/16/2009 | US20090180954 Biokinetics of fast-clearing polypeptides |
| 07/16/2009 | US20090180953 Invention concerning GLP-1 and exendin |
| 07/16/2009 | US20090180952 Ligands binding the complex of urokinase-type plasminogen activator (uppa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 07/16/2009 | US20090180950 Polychromatic, diversely-sized particles for angiography |
| 07/16/2009 | US20090179176 Fluorescent substance- or contrast medium-containing latex polymer particles, and a process to produce the same |
| 07/16/2009 | CA2711426A1 N-alkoxyamide conjugates as imaging agents |
| 07/16/2009 | CA2710567A1 Transgenic non-human animals expressing human blood clotting factors |
| 07/15/2009 | EP2078460A1 Process for preparing concentrate thickener compositions |
| 07/15/2009 | EP1982188A4 Method to determine and biomarker for treatment efficacy with ssri, snri, and sari antidepressants |
| 07/15/2009 | EP1883428B1 Contrast agents |
| 07/15/2009 | EP1877569A4 Predicting treatment response in cancer subjects |
| 07/15/2009 | CN101484075A Patches and uses thereof |
| 07/15/2009 | CN101480494A Magnetic resonance contrast agent based on humanized antibody for diagnosing tumor |
| 07/15/2009 | CN101480493A Method for producing animal model of essential thrombocytopenia |
| 07/15/2009 | CN100512746C Optical sensor for in vivo detection of analyte and preparation method thereof |
| 07/14/2009 | US7560229 Methods of use of the enzymes of mycothiol synthesis |
| 07/14/2009 | US7560097 Drug containing ferrite particles encapsulated in lipidmembrane; contrast agent for imaging; antitumor agents |
| 07/14/2009 | US7560096 Diagnostic procedures using direct injection of gaseous hyperpolarized 129Xe and associated systems and products |
| 07/14/2009 | CA2439222C Identification of partial agonists of the a2a adenosine receptor |
| 07/14/2009 | CA2411414C A novel expanded porphyrin and a method for synthesis thereof |
| 07/09/2009 | WO2009086539A2 Treatment and prophylaxis of amyloidosis |
| 07/09/2009 | WO2009084680A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 07/09/2009 | US20090178153 G protein coupled receptors and uses thereof |
| 07/09/2009 | US20090176238 Cynomolgus Toll-Like Receptor 3 |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | US20090175797 Inflammation-Inhibitory Serum Factors and Uses Thereof |
| 07/09/2009 | US20090175796 Antibodies and related molecules that bind to 24p4c12 proteins |
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/09/2009 | US20090175794 Inhibitors of carbonic anhydrase ix |
| 07/09/2009 | US20090175793 Treatment of male sexual dysfunction |
| 07/09/2009 | US20090175792 Glycomimetic inhibitors of siglec-8 |
| 07/09/2009 | US20090175791 Anti-VEGF Antibody Compositions and Methods |
| 07/09/2009 | US20090175790 Cardiac arrhythmia treatment methods and biological pacemaker |
| 07/09/2009 | US20090175789 Antibody raised against the ldl receptor |
| 07/09/2009 | US20090175787 Use of fructose-based compounds for the diagnosis of cancer |
| 07/09/2009 | US20090175785 Self-Assembled Fmoc-Ff Hydrogels |
| 07/09/2009 | US20090175783 Compounds and imaging methods |
| 07/09/2009 | US20090175775 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II) |
| 07/09/2009 | CA2710984A1 Treatment and prophylaxis of amyloidosis |
| 07/08/2009 | EP2076557A1 Polylysine dendrimer contrast agent |
| 07/08/2009 | EP2076292A2 Contrast agents for detecting prostate cancer |
| 07/08/2009 | EP1670413A4 Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 07/08/2009 | EP1412175B1 Insulating and functionalizing fine metal-containing particles with comformal ultra-thin films |
| 07/08/2009 | EP1178830B1 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 07/08/2009 | CN101474414A Preparation and application of polymer-coated magnetic nanoparticle contrast agent |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/07/2009 | US7557577 using magnetic resonance contrast medium such as gadolinium and manganese complexes of diethylenetriaminepentaacetate and N-methylglucamine |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556927 Methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/07/2009 | US7556797 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 07/07/2009 | US7556796 Pproducing a tumorigenic mouse cell by introducing into the cell containing a recombinant oncogene operably linked to an inducible promoter, a recombinant gene of interest that functionally complements the oncogene and restores tumorigenicity without expression of the inducible recombinant oncogene |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/02/2009 | WO2009082720A2 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 07/02/2009 | WO2009081169A2 Biodegradable contrast agents |
| 07/02/2009 | WO2009080739A1 Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used |
| 07/02/2009 | WO2009080138A2 The use of the spin crossover complex [mx+(l2)hw]an)z as a magnetic resonance imaging contrast agent |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009053372A8 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 07/02/2009 | US20090171198 Powdered marker |
| 07/02/2009 | US20090169484 Iron-salen complex |
| 07/02/2009 | US20090169483 Fluorescent photoprobe for the imaging of endothelin receptors |
| 07/02/2009 | US20090169482 Silica-cored carrier particle |
| 07/02/2009 | US20090169481 Dendritic polymers and magnetic resonance imaging contrast agent employing the same |
| 07/02/2009 | US20090169480 Dendritic polymers and magnetic resonance imaging contrast agent employing the same |
| 07/02/2009 | US20090169479 Compounds Comprising Short Aminoalcohol Chains and Metal Complexes for Medical Imgaing |
| 07/02/2009 | US20090169478 In Vivo Imaging and Therapy with Magnetic Nanoparticle Conjugates |
| 07/02/2009 | US20090169477 Delaying or preventing onset of multiple sclerosis |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | US20090169474 Method for noninvasnely and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vno and in vno gene targeting in organs, tissues and cells |
| 07/02/2009 | US20090169473 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 07/02/2009 | DE202008010019U1 Pharmazeutische Formulierung von Kontrastmitteln A pharmaceutical formulation of contrast agents |